CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $90.09 ($36,036)
- 8-K Event Unregistered share sale · Shareholder rights changed
- 4 Planned sale SVP, CHIEF HR OFFICER sold 1,000 shares at $98.04 ($98,040)
- 4 Shares withheld for taxes SVP, CHIEF HR OFFICER gave up 1,710 shares (to pay taxes)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 400 shares at $98.42 ($39,368)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale Director sold 7,292 shares at $94.94 ($692,302)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 2,528 shares at $90.62 ($229,087)
- 144 Insider Sale of Securities
- 4 Open-market sale SVP, CHIEF HR OFFICER sold 1,763 shares at $91.10 ($160,609)
- 4 Open-market sale HEAD OF R&D, COO-NOVITIUM OPS sold 100,000 shares at an average $90.36 ($9,036,008)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 21,540 shares at an average $89.15 ($1,920,370)
- 4 Open-market sale Director sold 5,421 shares at $89.73 ($486,426)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 7 of 90 · 1,784 filings